(Q37813395)

23 August 2017

1 reference

title

Tumor focality in prostate cancer: implications for focal therapy (English)

1 reference

23 August 2017

1 reference

Markos Karavitakis

1

1 reference

23 August 2017

Hashim U Ahmed

2

1 reference

23 August 2017

Paul D Abel

3

1 reference

23 August 2017

Steven Hazell

4

1 reference

23 August 2017

Mathias H Winkler

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

23 November 2010

1 reference

Nature Reviews Clinical Oncology

23 August 2017

1 reference

23 August 2017

8

1 reference

23 August 2017

1

1 reference

23 August 2017

48-55

1 reference

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2010.190

23 August 2017

0 references

cites work

Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Will focal therapy become a standard of care for men with localized prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Focal prostate cryoablation: initial results show cancer control and potency preservation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Nipple involvement and multicentricity in breast cancer. A study on whole organ sections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Complete histologic serial sectioning of a prostate gland with adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Assessment of morphometric measurements of prostate carcinoma volume

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Focal or subtotal therapy for early stage prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Molecular analysis of multifocal prostate cancer lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Genetic basis and clonal evolution of human prostate cancer

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

31 March 2020

12 December 2020

Evidence of independent origin of multiple tumors from patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Molecular evidence supporting field effect in urothelial carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Morphometric studies of intra-prostatic volume relationships in localized prostatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Is tumor volume an independent prognostic factor in clinically localized prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Clinicopathological behavior of single focus prostate adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Active surveillance for the management of prostate cancer in a contemporary cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

A multi-institutional evaluation of active surveillance for low risk prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Active surveillance for favorable risk prostate cancer: what are the results, and how safe is it?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Delayed versus immediate surgical intervention and prostate cancer outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Image guided photothermal focal therapy for localized prostate cancer: phase I trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, N0 prostatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Predicting Unilateral Prostate Cancer Based on Biopsy Features: Implications for Focal Ablative Therapy—Results From the SEARCH Database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

A brachytherapy template approach to standardize saturation prostatic biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

31 March 2020

Prostate cancer imaging

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Is it time to consider a role for MRI before prostate biopsy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

The index lesion and the origin of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Gene promoter methylation in prostate tumor-associated stromal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.190

Predictive value of contralateral biopsies in unilaterally palpable prostate cancer

31 March 2020

1 reference

12 December 2020

The phenomenon of multifocality does not affect the biologic behavior of histologic prostate carcinoma

1 reference

12 December 2020

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

1 reference

12 December 2020

Small renal tumors: natural history, observation strategies and emerging modalities of energy based tumor ablation

1 reference

12 December 2020

Surgical management of early stage invasive breast cancer: a practice guideline.

1 reference

12 December 2020

Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen

1 reference

12 December 2020

Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer

1 reference

12 December 2020

Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21

1 reference

12 December 2020

Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C.

1 reference

12 December 2020

Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients

1 reference

12 December 2020

Targeted focal therapy: a minimally invasive ablation technique for early prostate cancer.

1 reference

12 December 2020

Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer

1 reference

12 December 2020

Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen

1 reference

12 December 2020

Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin

1 reference

12 December 2020

10.1038/NRCLINONC.2010.190

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference